NASDAQ : KURA
Kura Oncology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.26 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 912.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Kura Oncology, Inc. (KURA) reported revenue of 77.22M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 77.22M | 67.48M | 53.88M | |||
| Cost of Revenue | 260.03M | 251.13M | 169.97M | 115.23M | 92.81M | |
| Gross Profit | -182.81M | -183.65M | -116.08M | -115.23M | -92.81M | |
| Selling, General & Admin | 135.28M | 119.98M | 77.11M | 50.57M | 47.05M | 46.54M |
| Research & Development | 84.72M | |||||
| Operating Expenses | 135.28M | 119.98M | 77.11M | 50.57M | 47.05M | 131.26M |
| Operating Income | -318.09M | -303.63M | -193.19M | -165.80M | -139.87M | -131.26M |
| Interest Expense | -1.42M | -1.51M | -1.62M | -1.55M | -229.00K | -414.00K |
| Interest & Investment Income | 14.33M | 18.29M | 9.71M | 5.30M | 5.86M | 5.60M |
| EBT Excluding Unusual Items | -305.18M | -286.86M | -185.11M | -162.05M | -134.23M | -126.08M |
| Gain (Loss) on Sale of Investments | 8.49M | 8.49M | 13.14M | 9.42M | -1.61M | -4.39M |
| Pretax Income | -296.69M | -278.37M | -171.97M | -152.63M | -135.84M | -130.47M |
| Income Tax Expense | 84.00K | 297.00K | 2.02M | |||
| Net Income | -296.77M | -278.67M | -173.98M | -152.63M | -135.84M | -130.47M |
| Net Income to Common | -296.77M | -278.67M | -173.98M | -152.63M | -135.84M | -130.47M |
| Shares Outstanding (Basic) | 88.29M | 87.68M | 86.16M | 73.23M | 66.99M | 66.35M |
| Shares Outstanding (Diluted) | 88.29M | 87.68M | 86.16M | 73.23M | 66.99M | 66.35M |
| EPS (Basic) | -3.36 | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 |
| EPS (Diluted) | -3.36 | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 |
| Free Cash Flow | -117.43M | -70.70M | 133.84M | -124.99M | -110.69M | -105.70M |
| Free Cash Flow Per Share | -1.33 | -0.81 | 1.55 | -1.71 | -1.65 | -1.59 |
| Gross Margin | -236.72% | -272.14% | -215.44% | |||
| Operating Margin | -411.90% | -449.94% | -358.54% | |||
| Profit Margin | -384.30% | -412.95% | -322.89% | |||
| Free Cash Flow Margin | -152.06% | -104.76% | 248.40% | |||
| EBITDA | -316.80M | -302.60M | -192.35M | -164.96M | -139.11M | -130.70M |
| D&A For EBITDA | 1.29M | 1.03M | 848.00K | 849.00K | 759.00K | 558.00K |
| EBIT | -318.09M | -303.63M | -193.19M | -165.80M | -139.87M | -131.26M |
| Revenue as Reported | 77.22M | 67.48M | 53.88M | |||
| Advertising Expenses | 2.80M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 70.24M | 149.10M | 224.46M | 37.32M | 51.80M | 90.67M |
| Short-Term Investments | 448.78M | 518.14M | 502.93M | 386.64M | 386.18M | 427.29M |
| Cash & Short-Term Investments | 519.02M | 667.24M | 727.39M | 423.96M | 437.99M | 517.96M |
| Accounts Receivable | 9.45M | 8.80M | 2.06M | |||
| Other Receivables | 3.60M | 3.80M | 3.30M | 1.10M | 900.00K | 1.40M |
| Receivables | 13.05M | 12.60M | 5.36M | 1.10M | 900.00K | 1.40M |
| Inventory | 2.48M | 413.00K | ||||
| Prepaid Expenses | 24.88M | 28.41M | 12.07M | 7.42M | 7.54M | 2.93M |
| Total Current Assets | 559.44M | 708.66M | 744.83M | 432.48M | 446.43M | 522.29M |
| Property, Plant & Equipment | 14.62M | 15.16M | 7.49M | 8.85M | 6.38M | 8.25M |
| Other Long-Term Assets | 13.73M | 14.54M | 7.84M | 7.60M | 3.50M | 3.52M |
| Total Assets | 587.79M | 738.36M | 760.16M | 448.94M | 456.31M | 534.05M |
| Accounts Payable | 2.39M | 5.02M | 1.47M | 2.30M | 1.53M | 3.24M |
| Accrued Expenses | 52.58M | 61.08M | 46.42M | 31.46M | 20.21M | 16.96M |
| Current Portion of Long-Term Debt | 4.22M | 2.61M | ||||
| Current Portion of Leases | 1.29M | 1.28M | 1.88M | 1.51M | 2.32M | 2.26M |
| Current Income Taxes Payable | 59.00K | 239.00K | 2.06M | |||
| Current Unearned Revenue | 55.48M | 48.98M | 24.27M | |||
| Other Current Liabilities | 2.17M | 377.00K | ||||
| Total Current Liabilities | 118.19M | 116.97M | 78.71M | 35.26M | 24.06M | 22.45M |
| Long-Term Debt | 5.57M | 9.71M | 6.92M | 9.33M | 9.16M | |
| Long-Term Leases | 13.37M | 9.47M | 5.19M | 6.36M | 2.55M | 4.61M |
| Long-Term Unearned Revenue | 398.60M | 424.91M | 253.91M | |||
| Other Long-Term Liabilities | 3.62M | 3.17M | 1.79M | 705.00K | 265.00K | 375.00K |
| Total Liabilities | 539.36M | 564.23M | 346.52M | 51.66M | 36.03M | 27.44M |
| Common Stock | 9.00K | 9.00K | 8.00K | 7.00K | 7.00K | 7.00K |
| Additional Paid-In Capital | 1.37B | 1.35B | 1.31B | 1.12B | 997.11M | 941.36M |
| Retained Earnings | -1.32B | -1.17B | -895.42M | -721.44M | -568.81M | -432.97M |
| Comprehensive Income & Other | -1.21M | 1.02M | 764.00K | -1.27M | -8.03M | -1.79M |
| Shareholders' Equity | 48.43M | 174.13M | 413.64M | 397.27M | 420.28M | 506.61M |
| Total Liabilities & Equity | 587.79M | 738.36M | 760.16M | 448.94M | 456.31M | 534.05M |
| Total Debt | 24.45M | 20.46M | 16.59M | 17.20M | 14.02M | 6.88M |
| Net Cash (Debt) | 494.57M | 646.78M | 710.80M | 406.76M | 423.96M | 511.08M |
| Net Cash Per Share | 5.60 | 7.38 | 8.25 | 5.55 | 6.33 | 7.70 |
| Filing Date Shares Outstanding | 88.96M | 88.33M | 80.75M | 76.14M | 68.44M | 66.61M |
| Total Common Shares Outstanding | 88.95M | 87.86M | 78.23M | 74.35M | 68.31M | 66.57M |
| Working Capital | 441.25M | 591.69M | 666.12M | 397.22M | 422.37M | 499.83M |
| Book Value Per Share | 0.54 | 1.98 | 5.29 | 5.34 | 6.15 | 7.61 |
| Tangible Book Value | 48.43M | 174.13M | 413.64M | 397.27M | 420.28M | 506.61M |
| Tangible Book Value Per Share | 0.54 | 1.98 | 5.29 | 5.34 | 6.15 | 7.61 |
| Machinery | 3.90M | 3.84M | 3.21M | 2.77M | 2.60M | 1.99M |
| Leasehold Improvements | 7.29M | 6.92M | 1.74M | 1.54M | 1.54M | 1.53M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -296.77M | -278.67M | -173.98M | -152.63M | -135.84M | -130.47M |
| Depreciation & Amortization | 1.29M | 1.03M | 848.00K | 849.00K | 759.00K | 558.00K |
| Loss (Gain) From Sale of Investments | -4.95M | -8.49M | -13.14M | -9.42M | 1.61M | 4.39M |
| Stock-Based Compensation | 38.94M | 37.11M | 33.90M | 28.08M | 26.32M | 23.58M |
| Other Operating Activities | 461.00K | 515.00K | 523.00K | 477.00K | 73.00K | 611.00K |
| Change in Accounts Receivable | -4.87M | -6.74M | -2.06M | |||
| Change in Inventory | -2.48M | -413.00K | ||||
| Change in Accounts Payable | 1.64M | 4.50M | -1.63M | -924.00K | -802.00K | -2.52M |
| Change in Unearned Revenue | 152.15M | 195.72M | 278.18M | |||
| Change in Other Net Operating Assets | 2.84M | -8.62M | 11.68M | 8.74M | -2.18M | -706.00K |
| Operating Cash Flow | -111.76M | -64.06M | 134.32M | -124.82M | -110.06M | -104.55M |
| Capital Expenditures | -5.67M | -6.64M | -472.00K | -168.00K | -626.00K | -1.15M |
| Investment in Securities | 103.02M | -6.46M | -101.12M | 15.72M | 33.25M | -125.69M |
| Investing Cash Flow | 97.35M | -13.10M | -101.59M | 15.56M | 32.63M | -126.83M |
| Long-Term Debt Issued | 10.00M | |||||
| Long-Term Debt Repaid | -7.25M | |||||
| Net Debt Issued (Repaid) | 10.00M | -7.25M | ||||
| Issuance of Common Stock | 2.70M | 1.79M | 154.42M | 94.78M | 29.14M | 4.43M |
| Other Financing Activities | -575.00K | -611.00K | ||||
| Financing Cash Flow | 2.70M | 1.79M | 154.42M | 94.78M | 38.56M | -3.44M |
| Net Cash Flow | -11.71M | -75.36M | 187.14M | -14.48M | -38.87M | -234.82M |
| Free Cash Flow | -117.43M | -70.70M | 133.84M | -124.99M | -110.69M | -105.70M |
| Free Cash Flow Margin | -152.06% | -104.76% | 248.40% | |||
| Free Cash Flow Per Share | -1.33 | -0.81 | 1.55 | -1.71 | -1.65 | -1.59 |
| Levered Free Cash Flow | -165.88M | -141.73M | -55.93M | -63.90M | -63.67M | -60.41M |
| Unlevered Free Cash Flow | -164.99M | -140.78M | -54.92M | -62.93M | -63.53M | -60.15M |
| Cash Interest Paid | 998.00K | 998.00K | 1.10M | 1.06M | 73.00K | 784.00K |
| Change in Working Capital | 149.27M | 184.44M | 286.17M | 7.82M | -2.98M | -3.22M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 912.74M | 904.11M | 677.32M | 1.07B | 847.16M | 931.78M |
| Enterprise Value | 418.17M | 373.91M | 238.65M | 632.86M | 424.76M | 395.69M |
| Last Close Price | 10.26 | 10.39 | 8.71 | 14.38 | 12.41 | 14.00 |
| PS Ratio | 11.82 | 13.40 | 12.57 | |||
| PB Ratio | 18.84 | 5.19 | 1.64 | 2.69 | 2.02 | 1.84 |
| P/TBV Ratio | 18.85 | 5.19 | 1.64 | 2.69 | 2.02 | 1.84 |
| P/FCF Ratio | 5.06 | |||||
| P/OCF Ratio | 5.04 | |||||
| EV/Sales Ratio | 5.41 | 5.54 | 4.43 | |||
| EV/FCF Ratio | 1.78 | |||||
| Debt / Equity Ratio | 0.51 | 0.12 | 0.04 | 0.04 | 0.03 | 0.01 |
| Debt / FCF Ratio | 0.12 | |||||
| Net Debt / Equity Ratio | -10.21 | -3.71 | -1.72 | -1.02 | -1.01 | -1.01 |
| Net Debt / EBITDA Ratio | 1.56 | 2.14 | 3.69 | 2.47 | 3.05 | 3.91 |
| Net Debt / FCF Ratio | 4.21 | 9.15 | -5.31 | 3.25 | 3.83 | 4.83 |
| Asset Turnover | 0.12 | 0.09 | 0.09 | |||
| Quick Ratio | 4.50 | 5.81 | 9.31 | 12.05 | 18.24 | 23.13 |
| Current Ratio | 4.73 | 6.06 | 9.46 | 12.26 | 18.56 | 23.26 |
| Return on Equity (ROE) | -167.71% | -94.82% | -42.91% | -37.34% | -29.31% | -23.35% |
| Return on Assets (ROA) | -31.30% | -25.33% | -19.97% | -22.89% | -17.65% | -13.89% |
| Return on Capital Employed (ROCE) | -67.70% | -48.90% | -28.40% | -40.10% | -32.40% | -25.70% |
| Earnings Yield | -32.76% | -30.82% | -25.69% | -14.29% | -16.04% | -14.00% |
| FCF Yield | -12.87% | -7.82% | 19.76% | -11.70% | -13.07% | -11.34% |
| Buyback Yield / Dilution | -1.16% | -1.76% | -17.66% | -9.31% | -0.96% | -25.01% |